EpiBiologics
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $160M
Investors
- 9
About EpiBiologics
Founded in 2022 and based in California, US, EpiBiologics, Inc. operates as a biotechnology company that focuses on protein breakdown and targeting transmembrane and interfacial proteins. The company is co-founded by Rami Hannoush (CEO) and others. In July 2023, EpiBiologics, Inc. In January 2026, EpiBiologics, Inc.
Who invested in EpiBiologics
9 investors across 3 rounds
See all investors in EpiBiologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EpiBiologics
Who invested in EpiBiologics?
EpiBiologics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EpiBiologics raised?
EpiBiologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EpiBiologics last raise money?
EpiBiologics's most recent round on record is a Series B, in Jan 2026.
What does EpiBiologics do?
Founded in 2022 and based in California, US, EpiBiologics, Inc.
Where is EpiBiologics headquartered?
EpiBiologics is headquartered in San Mateo, US.
Which VCs invest in companies like EpiBiologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EpiBiologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EpiBiologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.